Eli Lilly (LLY) on Wednesday outlined a plan to invest at least $27 billion to build four new pharmaceutical manufacturing sites in the US. The pharmaceutical giant said that three of the planned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback